datrowayhcp.com

.com crawl

First seen 2026-04-17 · Last seen 2026-05-15 · ok HTTP/1.1 200 1277 ms crawled 2026-05-12

NL · 20.50.139.246 · AS8075 Microsoft Corporation

Reputation 95/100 weak security headers

Classifying

HTML metadata

Title
DATROWAY® (datopotamab deruxtecandlnk) | Information for HCPs
Description
Discover DATROWAY® (Datopotamab Deruxtecandlnk) in breast and lung cancer treatment with its targeted approach. Learn about this innovative therapy.
Language
en
Canonical
//datrowayhcp.com

Open Graph

url
https://datrowayhcp.com/
title
DATROWAY® (datopotamab deruxtecan-dlnk) | Information for HCPs
site name
DATROWAY® For US Healthcare Professionals
description
DATROWAY® is an FDA-approved treatment option. Please see full Prescribing Information and Important Safety Information.

Technology

Cookie consent
  • OneTrust
Fonts
  • Adobe Fonts
  • Google Fonts

Third-party hosts loaded (5)

  • fonts.googleapis.com×3
  • use.typekit.net×2
  • cdn.cookielaw.org×1
  • fonts.gstatic.com×1
  • p.typekit.net×1

Social

Contact

Phone
Address
st associated with datopotamab deruxtecan.Cancer Treat Rev. 2024

Registration

Registrar
Network Solutions, LLC
Created
2023-03-06
Expires
2029-03-06 1021 days left
Updated
2026-03-09
Name servers
  • ns10.worldnic.com
  • ns9.worldnic.com

DNS records live

NS
  • ns10.worldnic.com
  • ns9.worldnic.com
TXT
  • _vnzyfo9h4l36v2bb32gp74ynvv8so4l

Email authentication no MX

SPF
not published
DMARC
not published
DKIM
no key found at common selectors

Certificate (current)

DigiCert Global G2 TLS RSA SHA256 2020 CA1
from 2025-12-10 to 2026-12-10
Expires in 204 days

HTTP security headers

Header hygiene 30/100 Checked live page: https://datrowayhcp.com/

findings
  • missing HSTS
  • missing Content Security Policy
  • missing frame protection
  • missing content type protection
  • missing Referrer Policy
  • missing Permissions Policy

Links to (6)

Linked from (2)